US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Provident

20.59

-0.3300-1.58%

Post-market: 20.590.00000.00%17:18 EDT

Volume:822.71K

Turnover:16.98M

Market Cap:2.69B

PE:9.23

High:20.81

Open:20.80

Low:20.50

Close:20.92

52wk High:23.98

52wk Low:14.34

Shares:130.62M

Float Shares:126.13M

Volume Ratio:0.66

T/O Rate:0.65%

Dividend:0.96

Dividend Rate:4.66%

EPS(TTM):2.23

EPS(LYR):2.23

ROE:10.72%

ROA:1.19%

PB:0.95

PE(LYR):9.23

Loading ...

Overview Company News Filings

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

Press Release: Immatics Announces Third Quarter 2025 Financial Results and Business Update

3 Dividend Stocks You Should Know With Yields Up To 9.7%

Simply Wall St.

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Press Release: IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Press Release: The Metals Company Announces Third Quarter 2025 Corporate Update

2025 AGM Chairman’s Address

Press Release: 2025 AGM Chairman's Address

3 Reliable Dividend Stocks With At Least 3.4% Yield To Enhance Your Portfolio

Simply Wall St.

Ivanhoe Electric secures $200M bridge loan for Arizona copper mine

Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results

Press Release: BeyondSpring Reports Third--Quarter 2025 Financial Results and Provides Corporate Update

Provident Financial Services Inc - Announces Blackout Period for Directors and Officers - SEC Filing

THOMSON REUTERS

Nyse Order Imbalance 76916.0 Shares on Sell Side

THOMSON REUTERS

Top 3 Dividend Stocks To Enhance Your Portfolio

Simply Wall St.

George Lista, President and CEO, Reports Disposal of Provident Financial Services Inc. Common Shares

Press Release: ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PFS/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","market":"US","secType":"STK","nameCN":"Provident","latestPrice":20.59,"timestamp":1774641600000,"preClose":20.92,"halted":0,"volume":822714,"hourTrading":{"tag":"盘后","latestPrice":20.59,"preClose":20.59,"latestTime":"17:18 EDT","volume":181657,"amount":3740317.63,"timestamp":1774646304525,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015774378585086127,"floatShares":126131374,"shares":130622384,"eps":2.229999,"marketStatus":"Market Closed","change":-0.33,"latestTime":"03-27 16:00:00 EDT","open":20.8,"high":20.81,"low":20.5,"amount":16981606.76544,"amplitude":0.014818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.229999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1042693200000,"exchange":"NYSE","adjPreClose":20.92,"dividendRate":0.046625,"postHourTrading":{"tag":"盘后","latestPrice":20.59,"preClose":20.59,"latestTime":"17:18 EDT","volume":181657,"amount":3740317.63,"timestamp":1774646304525,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.655165,"impliedVol":0.198,"impliedVolPercentile":0.4263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","floatShares":126131374,"roa":"1.19%","roe":"10.72%","lyrEps":2.231753,"volumeRatio":0.655165,"shares":130622384,"dividePrice":0.96,"high":20.81,"amplitude":0.014818,"preClose":20.92,"low":20.5,"week52Low":14.335,"pbRate":"0.95","psRate":"3.10","week52High":23.9789,"institutionHeld":0.7226,"latestPrice":20.59,"eps":2.229999,"divideRate":0.046625,"volume":822714,"delay":0,"ttmEps":2.229999,"open":20.8,"prevYearClose":19.75,"prevWeekClose":20.29,"prevMonthClose":21.04,"prevQuarterClose":19.75,"fiveDayClose":20.29,"twentyDayClose":21.04,"sixtyDayClose":19.89,"dividendPayoutRate":0.4301551291742411,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.047123599311239044},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFS\",params:#limit:5,,,undefined,":[{"date":"2026-02-13","symbol":"PFS","amount":0.24,"announcedDate":"2026-01-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-13","defaultRemindTime":1770993000000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-13","currency":"USD","dateTimestamp":1770958800000,"payDate":"2026-02-27"},{"market":"US","date":"2026-01-27","symbol":"PFS","fiscalQuarterEnding":"2025/12","expectedEps":0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1769490000000,"reportTimeType":"post","actualEps":0.64},{"date":"2025-11-14","symbol":"PFS","amount":0.24,"announcedDate":"2025-10-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-11-28"},{"market":"US","date":"2025-10-29","symbol":"PFS","fiscalQuarterEnding":"2025/09","expectedEps":0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761710400000,"reportTimeType":"post","actualEps":0.55},{"date":"2025-08-15","symbol":"PFS","amount":0.24,"announcedDate":"2025-07-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-08-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFS\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-05-31","value":0.18,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-08-31","value":0.18,"currency":"USD"},{"executeDate":"2016-11-10","recordDate":"2016-11-15","paymentDate":"2016-11-30","value":0.18,"currency":"USD"},{"executeDate":"2017-02-13","recordDate":"2017-02-15","paymentDate":"2017-02-28","value":0.19,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-05-31","value":0.19,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1771992000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFS","date":"2026-03-26","current":9.233188,"percent":0.23737,"low":6.410614,"twenty":8.984755,"median":10.558495,"eighty":15.537315,"high":33.979783,"avg":13.038744,"sd":6.391734,"marketCap":2728938451},"quantilePoints":[{"date":"2021-04-01","current":17.749069,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1720790008},{"date":"2021-04-09","current":18.24715,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1769079438},{"date":"2021-04-16","current":18.405271,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1784409415},{"date":"2021-04-23","current":18.674076,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1810470378},{"date":"2021-04-30","current":14.042944,"twenty":12.721872,"median":16.669814,"eighty":18.884491,"marketCap":1833713567},{"date":"2021-05-07","current":15.049841,"twenty":12.721872,"median":16.625436,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-05-14","current":15.169001,"twenty":12.721872,"median":16.591954,"eighty":18.884491,"marketCap":1980752967},{"date":"2021-05-21","current":15.133253,"twenty":12.721872,"median":16.545238,"eighty":18.884491,"marketCap":1976085049},{"date":"2021-05-28","current":15.049841,"twenty":12.721872,"median":16.529666,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-06-04","current":15.043883,"twenty":12.721872,"median":16.506308,"eighty":18.884491,"marketCap":1964415256},{"date":"2021-06-11","current":14.722153,"twenty":12.721872,"median":16.44402,"eighty":18.884491,"marketCap":1922403999},{"date":"2021-06-18","current":13.679507,"twenty":12.721872,"median":16.40509,"eighty":18.884491,"marketCap":1786256407},{"date":"2021-06-25","current":14.227641,"twenty":12.721872,"median":16.3245,"eighty":18.884491,"marketCap":1857831141},{"date":"2021-07-02","current":13.500768,"twenty":12.721872,"median":16.302281,"eighty":18.884491,"marketCap":1762916819},{"date":"2021-07-09","current":13.244575,"twenty":12.721872,"median":16.261288,"eighty":18.884491,"marketCap":1729463411},{"date":"2021-07-16","current":12.976467,"twenty":12.721872,"median":16.250162,"eighty":18.884491,"marketCap":1694454030},{"date":"2021-07-23","current":12.55345,"twenty":12.69964,"median":16.222063,"eighty":18.884491,"marketCap":1639217007},{"date":"2021-07-30","current":10.433885,"twenty":12.684833,"median":16.184117,"eighty":18.884491,"marketCap":1680450278},{"date":"2021-08-06","current":10.849309,"twenty":12.675728,"median":16.148152,"eighty":18.884491,"marketCap":1747357095},{"date":"2021-08-13","current":10.552042,"twenty":12.660863,"median":16.109223,"eighty":18.884491,"marketCap":1699480276},{"date":"2021-08-20","current":10.381313,"twenty":12.614911,"median":16.079724,"eighty":18.884491,"marketCap":1671983067},{"date":"2021-08-27","current":10.571012,"twenty":12.560516,"median":16.051403,"eighty":18.884491,"marketCap":1702535521},{"date":"2021-09-03","current":10.362343,"twenty":12.528973,"median":16.012247,"eighty":18.884491,"marketCap":1668927821},{"date":"2021-09-10","current":10.43348,"twenty":12.478039,"median":15.976834,"eighty":18.884491,"marketCap":1680384992},{"date":"2021-09-17","current":10.542557,"twenty":12.463634,"median":15.915973,"eighty":18.884491,"marketCap":1697952653},{"date":"2021-09-24","current":10.841334,"twenty":12.367008,"median":15.852207,"eighty":18.884491,"marketCap":1746072768},{"date":"2021-10-01","current":11.315583,"twenty":12.317066,"median":15.827979,"eighty":18.884491,"marketCap":1822453904},{"date":"2021-10-08","current":11.718695,"twenty":12.271397,"median":15.788905,"eighty":18.884491,"marketCap":1887377870},{"date":"2021-10-15","current":11.713953,"twenty":12.250326,"median":15.716295,"eighty":18.884491,"marketCap":1886614059},{"date":"2021-10-22","current":11.808802,"twenty":12.188782,"median":15.680935,"eighty":18.884491,"marketCap":1901890286},{"date":"2021-10-29","current":11.169949,"twenty":12.144658,"median":15.649322,"eighty":18.884491,"marketCap":1912127768},{"date":"2021-11-05","current":11.584988,"twenty":12.022084,"median":15.636232,"eighty":18.884491,"marketCap":1983176134},{"date":"2021-11-12","current":11.413559,"twenty":11.87183,"median":15.555472,"eighty":18.877325,"marketCap":1953830070},{"date":"2021-11-19","current":11.06619,"twenty":11.803248,"median":15.475641,"eighty":18.822017,"marketCap":1894365677},{"date":"2021-11-26","current":10.935362,"twenty":11.752841,"median":15.361209,"eighty":18.799671,"marketCap":1871969996},{"date":"2021-12-03","current":10.660174,"twenty":11.700674,"median":15.25837,"eighty":18.766081,"marketCap":1824861840},{"date":"2021-12-10","current":10.64664,"twenty":11.597269,"median":15.189807,"eighty":18.713257,"marketCap":1822545046},{"date":"2021-12-17","current":10.745888,"twenty":11.515514,"median":15.166494,"eighty":18.654746,"marketCap":1839534872},{"date":"2021-12-23","current":10.957919,"twenty":11.442431,"median":15.126556,"eighty":18.639247,"marketCap":1875831320},{"date":"2021-12-31","current":10.92634,"twenty":11.368446,"median":15.085589,"eighty":18.621596,"marketCap":1870425466},{"date":"2022-01-07","current":11.738372,"twenty":11.326022,"median":15.058778,"eighty":18.579091,"marketCap":2009433139},{"date":"2022-01-14","current":11.729349,"twenty":11.326022,"median":15.040904,"eighty":18.531427,"marketCap":2007888610},{"date":"2022-01-21","current":10.863182,"twenty":11.299875,"median":15.028989,"eighty":18.489553,"marketCap":1859613758},{"date":"2022-01-28","current":11.023748,"twenty":11.261979,"median":15.001772,"eighty":18.453467,"marketCap":1851118845},{"date":"2022-02-04","current":11.088134,"twenty":11.181448,"median":14.930112,"eighty":18.423167,"marketCap":1861930553},{"date":"2022-02-11","current":10.92717,"twenty":11.115728,"median":14.912327,"eighty":18.41438,"marketCap":1834901283},{"date":"2022-02-18","current":10.92717,"twenty":11.065654,"median":14.87528,"eighty":18.386528,"marketCap":1834901283},{"date":"2022-02-25","current":10.732094,"twenty":11.023748,"median":14.820597,"eighty":18.371521,"marketCap":1802143926},{"date":"2022-03-04","current":10.629654,"twenty":11.007105,"median":14.772796,"eighty":18.349914,"marketCap":1784942161},{"date":"2022-03-11","current":10.652348,"twenty":10.957288,"median":14.734826,"eighty":18.315942,"marketCap":1788752883},{"date":"2022-03-18","current":10.806664,"twenty":10.92634,"median":14.709739,"eighty":18.308123,"marketCap":1814665792},{"date":"2022-03-25","current":10.720428,"twenty":10.866543,"median":14.669048,"eighty":18.291682,"marketCap":1800185049},{"date":"2022-04-01","current":10.629654,"twenty":10.847714,"median":14.635382,"eighty":18.253335,"marketCap":1784942161},{"date":"2022-04-08","current":10.053238,"twenty":10.819838,"median":14.583758,"eighty":18.229989,"marketCap":1688149823},{"date":"2022-04-14","current":10.071393,"twenty":10.805336,"median":14.512906,"eighty":18.210171,"marketCap":1691198401},{"date":"2022-04-22","current":10.171245,"twenty":10.764,"median":14.497563,"eighty":18.192392,"marketCap":1707965577},{"date":"2022-04-29","current":10.150722,"twenty":10.733654,"median":14.451873,"eighty":18.177577,"marketCap":1657856535},{"date":"2022-05-06","current":10.297502,"twenty":10.713769,"median":14.383195,"eighty":18.14275,"marketCap":1681829155},{"date":"2022-05-13","current":9.954658,"twenty":10.67461,"median":14.304676,"eighty":18.117189,"marketCap":1625834598},{"date":"2022-05-20","current":10.078233,"twenty":10.650249,"median":14.249341,"eighty":18.096905,"marketCap":1646017372},{"date":"2022-05-27","current":10.572534,"twenty":10.629654,"median":14.193648,"eighty":18.064002,"marketCap":1726748469},{"date":"2022-06-03","current":10.412344,"twenty":10.620376,"median":14.117725,"eighty":18.057139,"marketCap":1700585614},{"date":"2022-06-10","current":10.000427,"twenty":10.605236,"median":13.994542,"eighty":18.016495,"marketCap":1633309699},{"date":"2022-06-17","current":9.92262,"twenty":10.570637,"median":13.872371,"eighty":17.998745,"marketCap":1620602026},{"date":"2022-06-24","current":10.165194,"twenty":10.552314,"median":13.685465,"eighty":17.991294,"marketCap":1660220065},{"date":"2022-07-01","current":10.513034,"twenty":10.530137,"median":13.611721,"eighty":17.968495,"marketCap":1717030837},{"date":"2022-07-08","current":10.31623,"twenty":10.524934,"median":13.456373,"eighty":17.95339,"marketCap":1684887900},{"date":"2022-07-15","current":10.288769,"twenty":10.512341,"median":13.392091,"eighty":17.910649,"marketCap":1680402839},{"date":"2022-07-22","current":10.613725,"twenty":10.505887,"median":13.327225,"eighty":17.849237,"marketCap":1733476061},{"date":"2022-07-29","current":11.467199,"twenty":10.505887,"median":13.302306,"eighty":17.813962,"marketCap":1809111112},{"date":"2022-08-05","current":11.377758,"twenty":10.505887,"median":13.239282,"eighty":17.786291,"marketCap":1795000639},{"date":"2022-08-12","current":11.739288,"twenty":10.505887,"median":13.221695,"eighty":17.762714,"marketCap":1852037025},{"date":"2022-08-19","current":11.748717,"twenty":10.505887,"median":13.209959,"eighty":17.748875,"marketCap":1853524605},{"date":"2022-08-26","current":11.296118,"twenty":10.505887,"median":13.188531,"eighty":17.733901,"marketCap":1782120768},{"date":"2022-09-02","current":10.848234,"twenty":10.505887,"median":13.150076,"eighty":17.684237,"marketCap":1711460720},{"date":"2022-09-09","current":10.928381,"twenty":10.505887,"median":13.130958,"eighty":17.66138,"marketCap":1724105150},{"date":"2022-09-16","current":11.036817,"twenty":10.505887,"median":13.113536,"eighty":17.644475,"marketCap":1741212319},{"date":"2022-09-23","current":10.980242,"twenty":10.505887,"median":13.081395,"eighty":17.623016,"marketCap":1732286840},{"date":"2022-09-30","current":9.193418,"twenty":10.478391,"median":13.065324,"eighty":17.59628,"marketCap":1450390441},{"date":"2022-10-07","current":9.075554,"twenty":10.469523,"median":13.052449,"eighty":17.561143,"marketCap":1431795692},{"date":"2022-10-14","current":9.580013,"twenty":10.437974,"median":13.034632,"eighty":17.546569,"marketCap":1511381219},{"date":"2022-10-21","current":9.716736,"twenty":10.425892,"median":13.011756,"eighty":17.514492,"marketCap":1532951128},{"date":"2022-10-28","current":10.271339,"twenty":10.389888,"median":12.992653,"eighty":17.479985,"marketCap":1683636796},{"date":"2022-11-04","current":10.266754,"twenty":10.377223,"median":12.955005,"eighty":17.444428,"marketCap":1682885173},{"date":"2022-11-11","current":10.291061,"twenty":10.357421,"median":12.934931,"eighty":17.408903,"marketCap":1686869566},{"date":"2022-11-18","current":10.064186,"twenty":10.320716,"median":12.924436,"eighty":17.359105,"marketCap":1649681083},{"date":"2022-11-25","current":10.272911,"twenty":10.310098,"median":12.883192,"eighty":17.323674,"marketCap":1683894487},{"date":"2022-12-02","current":10.204848,"twenty":10.293993,"median":12.857307,"eighty":17.216387,"marketCap":1672737942},{"date":"2022-12-09","current":9.973436,"twenty":10.282719,"median":12.842174,"eighty":17.162345,"marketCap":1634805690},{"date":"2022-12-16","current":9.360873,"twenty":10.269156,"median":12.829982,"eighty":17.036971,"marketCap":1534396787},{"date":"2022-12-23","current":9.719335,"twenty":10.253097,"median":12.811402,"eighty":16.964208,"marketCap":1593154590},{"date":"2022-12-30","current":9.69211,"twenty":10.230259,"median":12.79325,"eighty":16.866633,"marketCap":1588691972},{"date":"2023-01-06","current":9.896298,"twenty":10.216454,"median":12.770698,"eighty":16.761899,"marketCap":1622161606},{"date":"2023-01-13","current":10.150398,"twenty":10.193425,"median":12.743914,"eighty":16.690368,"marketCap":1663812707},{"date":"2023-01-20","current":10.213923,"twenty":10.187062,"median":12.725033,"eighty":16.523587,"marketCap":1674225482},{"date":"2023-01-27","current":9.790009,"twenty":10.173843,"median":12.690346,"eighty":16.324736,"marketCap":1719595430},{"date":"2023-02-03","current":10.396723,"twenty":10.16752,"median":12.677807,"eighty":16.256402,"marketCap":1826163591},{"date":"2023-02-10","current":10.238158,"twenty":10.16752,"median":12.667312,"eighty":16.23143,"marketCap":1798311961},{"date":"2023-02-17","current":10.259586,"twenty":10.15802,"median":12.637027,"eighty":16.127135,"marketCap":1802075695},{"date":"2023-02-24","current":10.011024,"twenty":10.149032,"median":12.580612,"eighty":16.062409,"marketCap":1758416384},{"date":"2023-03-03","current":9.946656,"twenty":10.12732,"median":12.54984,"eighty":16.029311,"marketCap":1747110222},{"date":"2023-03-10","current":8.806492,"twenty":10.110262,"median":12.491259,"eighty":15.99002,"marketCap":1546842669},{"date":"2023-03-17","current":8.551231,"twenty":10.087476,"median":12.467781,"eighty":15.924154,"marketCap":1502006690},{"date":"2023-03-24","current":8.308734,"twenty":10.075497,"median":12.378703,"eighty":15.861307,"marketCap":1459412470},{"date":"2023-03-31","current":8.159832,"twenty":10.060803,"median":12.352386,"eighty":15.839714,"marketCap":1433258125},{"date":"2023-04-06","current":7.704617,"twenty":10.04356,"median":12.287536,"eighty":15.796939,"marketCap":1353300555},{"date":"2023-04-14","current":7.832247,"twenty":10.027135,"median":12.261119,"eighty":15.730693,"marketCap":1375718565},{"date":"2023-04-21","current":7.74716,"twenty":10.017452,"median":12.211348,"eighty":15.694,"marketCap":1360773225},{"date":"2023-04-28","current":7.593207,"twenty":9.999766,"median":12.160062,"eighty":15.664957,"marketCap":1307717267},{"date":"2023-05-05","current":6.573548,"twenty":9.989771,"median":12.09154,"eighty":15.642667,"marketCap":1132109520},{"date":"2023-05-12","current":6.495446,"twenty":9.971621,"median":11.987273,"eighty":15.600987,"marketCap":1118658713},{"date":"2023-05-19","current":7.029498,"twenty":9.961387,"median":11.888242,"eighty":15.530275,"marketCap":1210634281},{"date":"2023-05-26","current":7.046909,"twenty":9.952827,"median":11.808802,"eighty":15.39865,"marketCap":1213632756},{"date":"2023-06-02","current":7.116551,"twenty":9.943684,"median":11.780347,"eighty":15.324881,"marketCap":1225626656},{"date":"2023-06-09","current":7.90873,"twenty":9.929925,"median":11.738372,"eighty":15.203096,"marketCap":1362057268},{"date":"2023-06-16","current":7.934846,"twenty":9.905841,"median":11.713953,"eighty":15.174007,"marketCap":1366554981},{"date":"2023-06-23","current":7.221014,"twenty":9.886325,"median":11.649929,"eighty":15.134319,"marketCap":1243617506},{"date":"2023-06-30","current":7.260188,"twenty":9.866996,"median":11.584988,"eighty":15.109317,"marketCap":1250364075},{"date":"2023-07-07","current":6.946798,"twenty":9.848756,"median":11.548897,"eighty":15.068412,"marketCap":1196391525},{"date":"2023-07-14","current":7.499583,"twenty":9.820363,"median":11.505283,"eighty":15.049841,"marketCap":1291593106},{"date":"2023-07-21","current":8.108951,"twenty":9.78572,"median":11.467199,"eighty":15.032889,"marketCap":1396539731},{"date":"2023-07-28","current":8.682159,"twenty":9.742349,"median":11.428126,"eighty":15.003286,"marketCap":1432521431},{"date":"2023-08-04","current":8.409258,"twenty":9.731294,"median":11.387173,"eighty":14.9415,"marketCap":1387493907},{"date":"2023-08-11","current":8.120111,"twenty":9.718285,"median":11.354912,"eighty":14.916422,"marketCap":1339785831},{"date":"2023-08-18","current":7.624539,"twenty":9.704927,"median":11.300777,"eighty":14.879018,"marketCap":1258018387},{"date":"2023-08-25","current":7.506329,"twenty":9.663774,"median":11.282731,"eighty":14.826043,"marketCap":1238514226},{"date":"2023-09-01","current":7.492689,"twenty":9.624389,"median":11.244446,"eighty":14.781733,"marketCap":1236263745},{"date":"2023-09-08","current":7.310828,"twenty":9.599052,"median":11.197237,"eighty":14.751943,"marketCap":1206257344},{"date":"2023-09-15","current":7.388119,"twenty":9.572255,"median":11.168825,"eighty":14.716388,"marketCap":1219010065},{"date":"2023-09-22","current":6.997117,"twenty":9.538302,"median":11.11225,"eighty":14.678775,"marketCap":1154496301},{"date":"2023-09-29","current":6.951652,"twenty":9.501581,"median":11.06619,"eighty":14.644899,"marketCap":1146994701},{"date":"2023-10-06","current":6.951652,"twenty":9.471361,"median":11.046743,"eighty":14.595078,"marketCap":1146994701},{"date":"2023-10-13","current":6.792523,"twenty":9.431033,"median":11.012054,"eighty":14.515019,"marketCap":1120739099},{"date":"2023-10-20","current":6.542463,"twenty":9.372419,"median":10.980475,"eighty":14.499896,"marketCap":1079480297},{"date":"2023-10-27","current":7.170747,"twenty":9.358917,"median":10.957919,"eighty":14.471655,"marketCap":1076479657},{"date":"2023-11-03","current":7.537213,"twenty":9.227549,"median":10.936586,"eighty":14.399708,"marketCap":1131493992},{"date":"2023-11-10","current":7.179977,"twenty":9.151165,"median":10.92634,"eighty":14.31961,"marketCap":1077865333},{"date":"2023-11-17","current":7.734589,"twenty":9.108811,"median":10.883634,"eighty":14.267749,"marketCap":1161124242},{"date":"2023-11-24","current":7.594687,"twenty":9.078197,"median":10.857,"eighty":14.214839,"marketCap":1140121995},{"date":"2023-12-01","current":7.60468,"twenty":8.976162,"median":10.840069,"eighty":14.143037,"marketCap":1141622155},{"date":"2023-12-08","current":8.214253,"twenty":8.928966,"median":10.82028,"eighty":14.03685,"marketCap":1233131947},{"date":"2023-12-15","current":9.103631,"twenty":8.896863,"median":10.805953,"eighty":13.930523,"marketCap":1366646233},{"date":"2023-12-22","current":9.083645,"twenty":8.896863,"median":10.78687,"eighty":13.759594,"marketCap":1363645912},{"date":"2023-12-29","current":9.223547,"twenty":8.892939,"median":10.761277,"eighty":13.668342,"marketCap":1384648159},{"date":"2024-01-05","current":8.743883,"twenty":8.862382,"median":10.745888,"eighty":13.56351,"marketCap":1312640455},{"date":"2024-01-12","current":8.583995,"twenty":8.806492,"median":10.720428,"eighty":13.408162,"marketCap":1288637886},{"date":"2024-01-19","current":8.309187,"twenty":8.772881,"median":10.697142,"eighty":13.342249,"marketCap":1247383472},{"date":"2024-01-26","current":8.828824,"twenty":8.752732,"median":10.656886,"eighty":13.316627,"marketCap":1325391819},{"date":"2024-02-02","current":9.490046,"twenty":8.752732,"median":10.64215,"eighty":13.30073,"marketCap":1218502920},{"date":"2024-02-09","current":8.830529,"twenty":8.752732,"median":10.629654,"eighty":13.236743,"marketCap":1133822213},{"date":"2024-02-16","current":9.326626,"twenty":8.752732,"median":10.620577,"eighty":13.221244,"marketCap":1197520090},{"date":"2024-02-23","current":8.865547,"twenty":8.752732,"median":10.61055,"eighty":13.209959,"marketCap":1138318534},{"date":"2024-03-01","current":8.801346,"twenty":8.74965,"median":10.589265,"eighty":13.19135,"marketCap":1130075279},{"date":"2024-03-08","current":8.986315,"twenty":8.743883,"median":10.567288,"eighty":13.154274,"marketCap":1153824926},{"date":"2024-03-15","current":8.329352,"twenty":8.723902,"median":10.538449,"eighty":13.128485,"marketCap":1069472190},{"date":"2024-03-22","current":8.96157,"twenty":8.698898,"median":10.5269,"eighty":13.112465,"marketCap":1150647615},{"date":"2024-03-28","current":8.466976,"twenty":8.693607,"median":10.517516,"eighty":13.098537,"marketCap":1087142753},{"date":"2024-04-05","current":8.466976,"twenty":8.653336,"median":10.488954,"eighty":13.065324,"marketCap":1087142753},{"date":"2024-04-12","current":7.990046,"twenty":8.61897,"median":10.476162,"eighty":13.052449,"marketCap":1025905922},{"date":"2024-04-19","current":8.671317,"twenty":8.578848,"median":10.466677,"eighty":13.034632,"marketCap":1040072426},{"date":"2024-04-26","current":9.585747,"twenty":8.579877,"median":10.437517,"eighty":13.020302,"marketCap":1149752791},{"date":"2024-05-03","current":9.605463,"twenty":8.579877,"median":10.431596,"eighty":12.999364,"marketCap":1152117669},{"date":"2024-05-10","current":10.091416,"twenty":8.579877,"median":10.40199,"eighty":12.962642,"marketCap":1210404831},{"date":"2024-05-17","current":10.167149,"twenty":8.579877,"median":10.387579,"eighty":12.944965,"marketCap":1219488545},{"date":"2024-05-24","current":9.554974,"twenty":8.579877,"median":10.368229,"eighty":12.926046,"marketCap":1146061860},{"date":"2024-05-31","current":15.595237,"twenty":8.579877,"median":10.368229,"eighty":12.928956,"marketCap":1870555147},{"date":"2024-06-07","current":14.804645,"twenty":8.579877,"median":10.368229,"eighty":12.944965,"marketCap":1775728393},{"date":"2024-06-14","current":14.479745,"twenty":8.579877,"median":10.368229,"eighty":12.974084,"marketCap":1736758494},{"date":"2024-06-21","current":14.609705,"twenty":8.578848,"median":10.365511,"eighty":13.001042,"marketCap":1752346453},{"date":"2024-06-28","current":15.541087,"twenty":8.578848,"median":10.365511,"eighty":13.028149,"marketCap":1864060164},{"date":"2024-07-05","current":15.400297,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":1847173207},{"date":"2024-07-12","current":17.403852,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":2087487584},{"date":"2024-07-19","current":19.212466,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2304420021},{"date":"2024-07-26","current":32.346496,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2473083727},{"date":"2024-08-02","current":29.436843,"twenty":8.578848,"median":10.365511,"eighty":13.071794,"marketCap":2250623276},{"date":"2024-08-09","current":28.842709,"twenty":8.578848,"median":10.365511,"eighty":13.113823,"marketCap":2205198173},{"date":"2024-08-16","current":30.822445,"twenty":8.578848,"median":10.365511,"eighty":13.134508,"marketCap":2356560887},{"date":"2024-08-23","current":32.631515,"twenty":8.578848,"median":10.365511,"eighty":13.176313,"marketCap":2494875092},{"date":"2024-08-30","current":32.546181,"twenty":8.578848,"median":10.365511,"eighty":13.215944,"marketCap":2488350837},{"date":"2024-09-06","current":31.197913,"twenty":8.578848,"median":10.365511,"eighty":13.228055,"marketCap":2385267609},{"date":"2024-09-13","current":31.300313,"twenty":8.578848,"median":10.365511,"eighty":13.30073,"marketCap":2393096715},{"date":"2024-09-20","current":32.187781,"twenty":8.578848,"median":10.365511,"eighty":13.316627,"marketCap":2460948967},{"date":"2024-09-27","current":31.283246,"twenty":8.578848,"median":10.365511,"eighty":13.405115,"marketCap":2391791864},{"date":"2024-10-04","current":30.429912,"twenty":8.578848,"median":10.365511,"eighty":13.64376,"marketCap":2326549315},{"date":"2024-10-11","current":32.136581,"twenty":8.578848,"median":10.365511,"eighty":13.888037,"marketCap":2457034414},{"date":"2024-10-18","current":33.314182,"twenty":8.578848,"median":10.365511,"eighty":14.144229,"marketCap":2547069132},{"date":"2024-10-25","current":31.88058,"twenty":8.578848,"median":10.365511,"eighty":14.323115,"marketCap":2437461649},{"date":"2024-11-01","current":26.079311,"twenty":8.578848,"median":10.365511,"eighty":14.468915,"marketCap":2459644116},{"date":"2024-11-08","current":29.303632,"twenty":8.578848,"median":10.365511,"eighty":14.501405,"marketCap":2763742765},{"date":"2024-11-15","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.577215,"marketCap":2792450197},{"date":"2024-11-22","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.642195,"marketCap":2792450197},{"date":"2024-11-29","current":29.220619,"twenty":8.578848,"median":10.365511,"eighty":14.720538,"marketCap":2755913466},{"date":"2024-12-06","current":28.72254,"twenty":8.578848,"median":10.365511,"eighty":14.772155,"marketCap":2708937668},{"date":"2024-12-13","current":28.16912,"twenty":8.578848,"median":10.365511,"eighty":14.811522,"marketCap":2656742337},{"date":"2024-12-20","current":26.370502,"twenty":8.578848,"median":10.365511,"eighty":14.879507,"marketCap":2487107512},{"date":"2024-12-27","current":26.107627,"twenty":8.578848,"median":10.365511,"eighty":14.930682,"marketCap":2462314730},{"date":"2025-01-03","current":26.19064,"twenty":8.578848,"median":10.365511,"eighty":15.008136,"marketCap":2470144030},{"date":"2025-01-10","current":24.945443,"twenty":8.578722,"median":10.36461,"eighty":15.045075,"marketCap":2352704535},{"date":"2025-01-17","current":26.730225,"twenty":8.578722,"median":10.36461,"eighty":15.087294,"marketCap":2521034477},{"date":"2025-01-24","current":26.232147,"twenty":8.578722,"median":10.36461,"eighty":15.170193,"marketCap":2474058679},{"date":"2025-01-31","current":20.975271,"twenty":8.578722,"median":10.36461,"eighty":15.27162,"marketCap":2423168232},{"date":"2025-02-07","current":21.686872,"twenty":8.578722,"median":10.36461,"eighty":15.43113,"marketCap":2505375878},{"date":"2025-02-14","current":21.065633,"twenty":8.578722,"median":10.36461,"eighty":15.506431,"marketCap":2433607298},{"date":"2025-02-21","current":20.489576,"twenty":8.578722,"median":10.36461,"eighty":15.601522,"marketCap":2367058251},{"date":"2025-02-28","current":20.614008,"twenty":8.578722,"median":10.36461,"eighty":15.733365,"marketCap":2381433247},{"date":"2025-03-07","current":19.427996,"twenty":8.578596,"median":10.36371,"eighty":15.909803,"marketCap":2244419279},{"date":"2025-03-14","current":19.373214,"twenty":8.58723,"median":10.384564,"eighty":16.110435,"marketCap":2238090520},{"date":"2025-03-21","current":19.113398,"twenty":8.626133,"median":10.390798,"eighty":16.250162,"marketCap":2208075312},{"date":"2025-03-28","current":19.282843,"twenty":8.679674,"median":10.422436,"eighty":16.324736,"marketCap":2227650448},{"date":"2025-04-04","current":17.498022,"twenty":8.697705,"median":10.433885,"eighty":16.538637,"marketCap":2021459018},{"date":"2025-04-11","current":16.594315,"twenty":8.729831,"median":10.450581,"eighty":16.720339,"marketCap":1917058294},{"date":"2025-04-17","current":17.498022,"twenty":8.74788,"median":10.472646,"eighty":16.838352,"marketCap":2021459018},{"date":"2025-04-25","current":14.654875,"twenty":8.784492,"median":10.48224,"eighty":16.926427,"marketCap":2161169063},{"date":"2025-05-02","current":15.142189,"twenty":8.798752,"median":10.513034,"eighty":16.926427,"marketCap":2233033814},{"date":"2025-05-09","current":15.159534,"twenty":8.804878,"median":10.526765,"eighty":16.926427,"marketCap":2235591607},{"date":"2025-05-16","current":15.505075,"twenty":8.82909,"median":10.533858,"eighty":16.926427,"marketCap":2286548985},{"date":"2025-05-23","current":14.787412,"twenty":8.855843,"median":10.556785,"eighty":16.926427,"marketCap":2180714431},{"date":"2025-05-30","current":14.884872,"twenty":8.8606,"median":10.572534,"eighty":16.926427,"marketCap":2195087025},{"date":"2025-06-06","current":14.619071,"twenty":8.875633,"median":10.60779,"eighty":16.926427,"marketCap":2155889043},{"date":"2025-06-13","current":15.000053,"twenty":8.887975,"median":10.619572,"eighty":16.926427,"marketCap":2212072818},{"date":"2025-06-20","current":14.30011,"twenty":8.911603,"median":10.626285,"eighty":16.928687,"marketCap":2108851463},{"date":"2025-06-27","current":15.850617,"twenty":8.946056,"median":10.641658,"eighty":16.928687,"marketCap":2337506362},{"date":"2025-07-03","current":16.710041,"twenty":8.946056,"median":10.65175,"eighty":16.928687,"marketCap":2464246506},{"date":"2025-07-11","current":16.648021,"twenty":8.954399,"median":10.683931,"eighty":16.928687,"marketCap":2455100310},{"date":"2025-07-18","current":16.4974,"twenty":8.954399,"median":10.718159,"eighty":16.928687,"marketCap":2432888120},{"date":"2025-07-25","current":10.379214,"twenty":8.954399,"median":10.725223,"eighty":16.928687,"marketCap":2396954859},{"date":"2025-08-01","current":10.305683,"twenty":8.954399,"median":10.733069,"eighty":16.928687,"marketCap":2379973707},{"date":"2025-08-08","current":10.124683,"twenty":8.954399,"median":10.733069,"eighty":16.928687,"marketCap":2338173949},{"date":"2025-08-15","current":10.899581,"twenty":8.954399,"median":10.730998,"eighty":16.928687,"marketCap":2517127428},{"date":"2025-08-22","current":10.633738,"twenty":8.954399,"median":10.730998,"eighty":16.928687,"marketCap":2455734076},{"date":"2025-08-29","current":11.255924,"twenty":8.954399,"median":10.756738,"eighty":16.928687,"marketCap":2599420644},{"date":"2025-09-05","current":11.380362,"twenty":8.954068,"median":10.786944,"eighty":16.930946,"marketCap":2628157958},{"date":"2025-09-12","current":11.312487,"twenty":8.954399,"median":10.806309,"eighty":16.928687,"marketCap":2612483060},{"date":"2025-09-19","current":11.493487,"twenty":8.954399,"median":10.823106,"eighty":16.928687,"marketCap":2654282788},{"date":"2025-09-26","current":11.0523,"twenty":8.984755,"median":10.848771,"eighty":16.928687,"marketCap":2552395949},{"date":"2025-10-03","current":11.018362,"twenty":8.984755,"median":10.865282,"eighty":16.928687,"marketCap":2544558500},{"date":"2025-10-10","current":10.876956,"twenty":8.984755,"median":10.902195,"eighty":16.928687,"marketCap":2511902462},{"date":"2025-10-17","current":10.113363,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2335559855},{"date":"2025-10-24","current":10.475363,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2419159313},{"date":"2025-10-31","current":9.425046,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2415196286},{"date":"2025-11-07","current":9.328196,"twenty":8.984755,"median":10.888266,"eighty":16.928687,"marketCap":2390378153},{"date":"2025-11-14","current":9.557624,"twenty":8.984755,"median":10.857,"eighty":16.928687,"marketCap":2449169700},{"date":"2025-11-21","current":9.205903,"twenty":8.984755,"median":10.840069,"eighty":16.928687,"marketCap":2359040255},{"date":"2025-11-28","current":9.812493,"twenty":8.984755,"median":10.820894,"eighty":16.928687,"marketCap":2514480892},{"date":"2025-12-05","current":10.210091,"twenty":8.984755,"median":10.806309,"eighty":16.928687,"marketCap":2616366351},{"date":"2025-12-12","current":10.628077,"twenty":8.984755,"median":10.780942,"eighty":16.928687,"marketCap":2723476706},{"date":"2025-12-19","current":10.801389,"twenty":8.984755,"median":10.756738,"eighty":16.928687,"marketCap":2767888316},{"date":"2025-12-26","current":10.444571,"twenty":8.984755,"median":10.741206,"eighty":16.928687,"marketCap":2676452648},{"date":"2026-01-02","current":10.067363,"twenty":8.984755,"median":10.729963,"eighty":16.928687,"marketCap":2579792084},{"date":"2026-01-09","current":10.3885,"twenty":8.984755,"median":10.718159,"eighty":16.685233,"marketCap":2662084185},{"date":"2026-01-16","current":10.342623,"twenty":8.984755,"median":10.6903,"eighty":16.559093,"marketCap":2650328171},{"date":"2026-01-23","current":10.862558,"twenty":8.984755,"median":10.681432,"eighty":16.43782,"marketCap":2783563003},{"date":"2026-01-30","current":9.968317,"twenty":8.984755,"median":10.656886,"eighty":16.315692,"marketCap":2902375266},{"date":"2026-02-06","current":10.569467,"twenty":8.984755,"median":10.64505,"eighty":16.315692,"marketCap":3077405998},{"date":"2026-02-13","current":10.309268,"twenty":8.984755,"median":10.637462,"eighty":16.315692,"marketCap":3001646428},{"date":"2026-02-20","current":10.295809,"twenty":8.984755,"median":10.627766,"eighty":16.315692,"marketCap":2997727829},{"date":"2026-02-27","current":9.936914,"twenty":8.984755,"median":10.621728,"eighty":16.286003,"marketCap":2893231870},{"date":"2026-03-06","current":9.538728,"twenty":8.984755,"median":10.611113,"eighty":16.080978,"marketCap":2777296077},{"date":"2026-03-13","current":9.157179,"twenty":8.984755,"median":10.607786,"eighty":15.806317,"marketCap":2666204234},{"date":"2026-03-20","current":9.098824,"twenty":8.984755,"median":10.569303,"eighty":15.687592,"marketCap":2649213717},{"date":"2026-03-26","current":9.372642,"twenty":8.984755,"median":10.558495,"eighty":15.537315,"marketCap":2728938451}],"updateTime":1774668223370},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFS\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584543559","title":"Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2584543559","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584543559?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:30","pubTimestamp":1763483400,"startTime":"0","endTime":"0","summary":"Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/18/3190331/0/en/Genmab-Announces-EPKINLY-epcoritamab-bysp-in-Combination-with-Rituximab-and-Lenalidomide-Approved-by-the-U-S-Food-and-Drug-Administration-for-the-Treatment-of-Relapsed-or-Refractor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","IE00B7SZL793.SGD","BK4006","CR","IE00B66KJ199.SGD","ORR","BK4211","BK4195","BK4161","CRS","IE00B19Z4B17.USD","IE0031619046.USD","LU0963586101.USD","PFS","BK4187"],"gpt_icon":0},{"id":"2584640789","title":"Press Release: Immatics Announces Third Quarter 2025 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2584640789","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584640789?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:00","pubTimestamp":1763380800,"startTime":"0","endTime":"0","summary":"randomized, controlled Phase 3 trial, SUPRAME, in previously treated. advanced melanoma ongoing; interim and final analyses will occur in 2026. -- Anzu-cel  PRAME Cell Therapy: One-time infusion continues to show. strong clinical benefit and favorable tolerability in 16 patients with. metastatic uveal melanoma in latest update on Phase 1b data presented at. the ESMO 2025 Presidential Symposium: cORR of 67%, mDOR of 11.0 months,mPFS of 8.5 months and mOS not reached at 14.3 months mFU. -- IMA203CD8 PRAME Cell Therapy : Phase 1a clinical trial ongoing with. next data update, including dose escalation data in ovarian cancer,melanoma and synovial sarcoma, planned to be presented at ESMO. -- TCR Bispecifics: IMA402 and IMA401 TCR Bispecifics achieved clinical. and durable responses in heavily pre-treated, last-line patients with a. -- TCR Bispecifics data support development opportunities for IMA402 PRAME. Bispecific in cutaneous melanoma, gynecologic cancers and in combination. with IMA401","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","IMTX","ORR","BK4195","IE0009354923.USD","BK4097","PFS","BK4211","ODD","BK4139","BK4183"],"gpt_icon":0},{"id":"2584629641","title":"3 Dividend Stocks You Should Know With Yields Up To 9.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584629641","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584629641?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:01","pubTimestamp":1763377308,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences mixed results, with the Dow Jones Industrial Average showing resilience despite recent declines, investors are increasingly turning their attention to dividend stocks as a potential source of steady income amidst market volatility. In this environment, understanding what makes a solid dividend stock—such as consistent payouts and strong financial health—can be crucial for those seeking stability and income in their investment portfolios.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3115000-choice2-main-header/1585186546248","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3115000-choice2-main-header/1585186546248"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/commercial-services/nysemkt-cix/compx-international/news/3-dividend-stocks-you-should-know-with-yields-up-to-97","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/commercial-services/nysemkt-cix/compx-international/news/3-dividend-stocks-you-should-know-with-yields-up-to-97","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0648000940.SGD","FMNB","LU0130103400.USD","LU1201861165.SGD","US7Y.BOND","FIBK","TLTW","TMF","BK4195","LU0566484027.USD","US5Y.BOND","PEBO","UBSI","IPG.AU","LU1559883803.SGD","US30Y.BOND","LU0477156797.USD","BK4144","PFS","BK4009","US3Y.BOND","BK4585","COLB","IPG","DHT","BK4143","US12M.BOND","US10Y.BOND","CZNC","BK7031","CIX","US2Y.BOND","BK4588","HTBK","BK4087","US6M.BOND","EBF","BK4211","LU0130518102.USD"],"gpt_icon":1},{"id":"2584864263","title":"Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2584864263","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584864263?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:00","pubTimestamp":1763377200,"startTime":"0","endTime":"0","summary":"Ziihera plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"12b9cc00d05cc390c8f725385f7a4061","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3188936/0/en/Zymeworks-Announces-Positive-HERIZON-GEA-01-Phase-3-Results-Supporting-Ziihera-zanidatamab-hrii-as-HER2-Targeted-Agent-of-Choice-and-New-Standard-of-Care-in-First-Line-HER2-Positiv.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4142","BK4124","BTC","SMP","BK4097","BK4195","BK4211","PFS","ORR","OS","CHH"],"gpt_icon":0},{"id":"2583950622","title":"Press Release: IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2583950622","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583950622?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:05","pubTimestamp":1763125500,"startTime":"0","endTime":"0","summary":"-- Topline data from Phase 3  clinical trial in advanced melanoma. presented at ESMO; data highlights improvements in PFS achieved in. overall population and across virtually all subgroups, although. statistical significance on the PFS primary endpoint was narrowly missed. -- Meeting scheduled with FDA in December to align on the design of a. potential new Phase 3 registrational trial for IO102-IO103 in patients. -- Pre-clinical data for additional T-win platform pipeline candidates IO112. targeting arginase 1 and IO170 targeting transforming growth factor. -<BETA> were presented at the Society for Immunotherapy of Cancer's. equivalents, which is expected to support operations through the first. Conference in London on November 18, 2025, and the Piper Sandler 37th. Annual Piper Sandler Healthcare Conference on December 3, 2025. NEW YORK, Nov. 14, 2025  -- IO Biotech , a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU1291159041.SGD","XLV","R","01698","LU1066051225.USD","LU0203345920.USD","SITC","SG9999001176.SGD","LU1917777945.USD","BK4080","MRK","LU1430594728.SGD","LABU","LU1941712348.USD","BK4588","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU1116320901.HKD","SG9999011746.SGD","IE0009355771.USD","XBI","IE00BSNM7G36.USD","SG9999014567.USD","LU0098860793.USD","LU1069347547.HKD","BK4108","IOBT","LU1035773651.USD","BK4231","LU0211331839.USD","LU0359201612.USD","LU1585245621.USD","BK4550","LU1023057109.AUD","SG9999014559.SGD","IE00BLSP4452.SGD","BK4559","LU0203347892.USD","LU1983299246.USD","LU0266013472.USD","LU2023250843.SGD","PFS","BK4232","LU0122379950.USD","IE00B2B36J28.USD","OS","LU0320765489.SGD"],"gpt_icon":1},{"id":"2583511169","title":"Press Release: The Metals Company Announces Third Quarter 2025 Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511169","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511169?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067660,"startTime":"0","endTime":"0","summary":"-- Total cash of approximately $115.6 million at September 30, 2025. -- $11.5 million cash used in operations for the quarter ended September 30,per share of $0.46 for the quarter ended September 30, 2025. During the. items, including share-based compensation impacted by one-time grants,fair value changes in the royalty and warrant liabilities, and the. Onshore, our development team continues to innovate, and I'm proud that we've successfully produced battery-grade manganese sulfate from a nodule-derived manganese silicate product in bench-scale trials -- further evidence of our ability to deliver the materials that modern industries demand. As the planet's largest source of manganese, polymetallic nodules hold vast potential to supply sectors from steelmaking and infrastructure to energy, defense and automotive manufacturing, where we're seeing automakers increasingly pivot toward manganese-rich cathode chemi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4168","NPV","BK4195","TMC","BK4563","PFS"],"gpt_icon":0},{"id":"2583560541","title":"2025 AGM Chairman’s Address","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560541","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560541?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037900,"startTime":"0","endTime":"0","summary":"American Rare Earths’ Flagship Halleck Creek Project is the fast-track development to secure a long-term supply of U.S. magnet metals for national security, defence, and manufacturingDENVER, Nov.  13,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187220/0/en/2025-AGM-Chairman-s-Address.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ARRNF","BK4168","BK4588","LU1894683264.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4229","IE0034235188.USD","LU1894683348.USD","LU0061475181.USD","PFS","IE00BGHQF748.EUR","BK4211","LU1883839398.USD","AGM","USA","BK4195","BK4135","STT"],"gpt_icon":0},{"id":"2583560352","title":"Press Release: 2025 AGM Chairman's Address","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560352","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560352?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:45","pubTimestamp":1763037900,"startTime":"0","endTime":"0","summary":"On behalf of the Board, I am pleased to present my address to shareholders for the 2025 Annual General Meeting at a pivotal moment for the Company and the U.S. rare earths industry. Heightened geopolitical tensions and recent restrictions on rare earths exports from China have accelerated U.S. government efforts to secure a permanent domestic mine-to-magnet supply chain.Against this backdrop, American Rare Earths is advancing its flagship Halleck Creek Rare Earths Project, a vital U.S. national asset aligned with President Trump's vision to reduce America's dependence on foreign minerals, enhance national security and drive job creation. As the U.S. currently has only one producing rare earths mine, Halleck Creek is the answer to ensure multiple points of domestic production to counter China's chokehold on upstream rare earths production for generations to come.During FY2025, the Company has delivered significant progress across technical, permitting and corporate fronts:. -- Resource ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4229","ARRNF","LU1883839398.USD","USA","IE00B3QW5Z07.USD","AGM","STT","IE00B64PRP62.GBP","BK7095","BK4168","BK4588","BK4211","LU0061475181.USD","LU1894683264.USD","ARR.AU","BK4135","BK4195","LU1894683348.USD","BK4585","IE0034235188.USD","IE00BGHQF748.EUR","PFS"],"gpt_icon":0},{"id":"2583560861","title":"3 Reliable Dividend Stocks With At Least 3.4% Yield To Enhance Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560861","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560861?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:02","pubTimestamp":1763031722,"startTime":"0","endTime":"0","summary":"As the Dow Jones Industrial Average reaches a new milestone, closing above 48,000 for the first time amid optimism over an impending end to the U.S. government shutdown, investors are keeping a close eye on market dynamics and potential opportunities. In such a mixed market environment, selecting reliable dividend stocks with solid yields can be an effective strategy to enhance portfolio stability and generate income.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7013000-choice1-main-header/1585186561056","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7013000-choice1-main-header/1585186561056"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/banks/nyse-rf/regions-financial/news/3-reliable-dividend-stocks-with-at-least-34-yield-to-enhance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/banks/nyse-rf/regions-financial/news/3-reliable-dividend-stocks-with-at-least-34-yield-to-enhance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HTBK","BK4195","BK7031","BK4588","IPG.AU","LU1883839398.USD","LU0648000940.SGD","LU0566484027.USD","BK4144","TLTW","TRNO","US5Y.BOND","US12M.BOND","PEBO","RF","LU1559883803.SGD","CZNC","BK4171","BK4009","EBF","COLB","US6M.BOND","FIBK","UBSI","BK4211","US30Y.BOND","US3Y.BOND","TMF","BK4585","BK4224","LU1201861165.SGD","US2Y.BOND","BK4087","LU0477156797.USD","LU0130518102.USD","LU0130103400.USD","LU1880398554.USD","ASC","PFS","US10Y.BOND","US7Y.BOND","IPG","FMNB","LU1880398471.USD"],"gpt_icon":1},{"id":"2583923375","title":"Ivanhoe Electric secures $200M bridge loan for Arizona copper mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2583923375","media":"Mining","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583923375?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:39","pubTimestamp":1762990740,"startTime":"0","endTime":"0","summary":"Ivanhoe said it is in talks with interested parties both project-level minority investment and long-term…","market":"us","thumbnail":"https://www.mining.com/wp-content/uploads/2025/11/ivanhoeelectricsantacruz.jpeg","type":0,"news_type":0,"thumbnails":["https://www.mining.com/wp-content/uploads/2025/11/ivanhoeelectricsantacruz.jpeg"],"rights":{"source":"mining_highlight","url":"https://www.mining.com/ivanhoe-electric-secures-200m-bridge-loan-for-arizona-copper-mine/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mining.com/ivanhoe-electric-secures-200m-bridge-loan-for-arizona-copper-mine/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mining_highlight","symbols":["QCmain","BK4195","MHGmain","NPV","BK4211","PFS","IRR"],"gpt_icon":0},{"id":"2582371776","title":"Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582371776","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582371776?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952400,"startTime":"0","endTime":"0","summary":"- Expanded data for VCN-01 (zabilugene almadenorepvec) in metastatic pancreatic ductal adenocarcinoma (PDAC) from the VIRAGE Phase 2b trial presented at the European Society for Medical Oncology (ESMO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186207/0/en/Theriva-Biologics-Reports-Third-Quarter-2025-Operational-Highlights-and-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","BK4097","BK4585","FAS","BK4588","BK4211","BK4195","PFS"],"gpt_icon":0},{"id":"2582373704","title":"Press Release: BeyondSpring Reports Third--Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373704","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373704?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948800,"startTime":"0","endTime":"0","summary":"-- Two SITC 2025 presentations: First-in-class dendritic cell . maturation agent Plinabulin drives immune re-sensitization in metastatic. NSCLC patients who had progressed after PD-1/L1 inhibitors with disease. control rate of 85% in combination with docetaxel and Keytruda. Mechanism. studies with MD Anderson collaborators showed DC maturation and M1. macrophage polarization via a Plinabulin specific GEF-H1 dependent. mechanism in responding patients with Plinabulin, PD-1 inhibitor and. -- SEED, co-founded by BeyondSpring with 38% equity share, successfully. -- SEED Named Finalist for 2025 Prix Galien USA \"Best Start-Up\" Award. Dr. Huang added, \"At SEED, which we co-founded with Lilly five years ago, we are excited that our RBM39 molecular-glue degrader has received IND clearance from both the US FDA and China NMPA. It is such an honor to be the only target protein degradation company nominated by the Prix Galien Foundation, recognizing our commitment to developing transformative medic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","OS","BK4017","BK4099","DC","TM","ORR","BK4195","PFS","BK4097","BK4588","BK4555","BK4211","BK4585","BK4139","03160","BK4604"],"gpt_icon":0},{"id":"2582656807","title":"Provident Financial Services Inc - Announces Blackout Period for Directors and Officers - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582656807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582656807?lang=en_us&edition=fundamental","pubTime":"2025-11-11 04:57","pubTimestamp":1762808244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM219:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PFS","BK4195","BK4211"],"gpt_icon":0},{"id":"2582078668","title":"Nyse Order Imbalance  76916.0 Shares on Sell Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2582078668","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582078668?lang=en_us&edition=fundamental","pubTime":"2025-11-11 04:50","pubTimestamp":1762807800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nAQN2L74UA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4195","PFS","BK4211"],"gpt_icon":0},{"id":"2582249801","title":"Top 3 Dividend Stocks To Enhance Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2582249801","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582249801?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:02","pubTimestamp":1762794128,"startTime":"0","endTime":"0","summary":"As the U.S. stock market shows signs of optimism with major indexes rebounding on hopes for a resolution to the government shutdown, investors are keenly observing opportunities to strengthen their portfolios. In such an environment, dividend stocks can offer a compelling mix of income and stability, making them an attractive option for those looking to enhance their investment strategy amidst ongoing economic developments.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7013000-choice1-main-header/1585186561056","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7013000-choice1-main-header/1585186561056"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/banks/nasdaq-indb/independent-bank/news/top-3-dividend-stocks-to-enhance-your-portfolio-32","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/banks/nasdaq-indb/independent-bank/news/top-3-dividend-stocks-to-enhance-your-portfolio-32","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FMNB","LU1066051498.USD","LU1066053197.SGD","BK4087","LU1941712348.USD","PFS","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU1066051225.USD","PEBO","PLOW","SG9999014542.SGD","IE0009355771.USD","LU1069347547.HKD","INDB","FIBK","LU2361045086.USD","LU1093756325.SGD","LU0106261372.USD","LU0265550359.USD","LU1941712264.USD","LU1585245621.USD","LU2023250843.SGD","COLB","BK4585","CZNC","LU0203347892.USD","LU1057294990.SGD","LU1162221912.USD","LU1699723380.USD","BK4534","LU1917777945.USD","LU0566484027.USD","LU1929549753.HKD","IE00BJT1NW94.SGD","LU2361044865.SGD","MRK","PFBC","SG9999001176.USD","SG9999014559.SGD","LU0006306889.USD","SG9999014575.USD","LU0058720904.USD","LU2106854487.HKD","LU1571399168.USD","LU1116320901.HKD","EBF","LU0965509010.AUD","LU0289739699.SGD","HTBK"],"gpt_icon":0},{"id":"2582805829","title":"George Lista, President and CEO, Reports Disposal of Provident Financial Services Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582805829","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582805829?lang=en_us&edition=fundamental","pubTime":"2025-11-11 00:24","pubTimestamp":1762791870,"startTime":"0","endTime":"0","summary":"George Lista, President and CEO of Prov Protection Plus, reported a disposal of common shares of Provident Financial Services Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Provident Financial Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL35RwHW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"George Lista, President and CEO, Reports Disposal of Provident Financial Services Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4211","BK4195"],"gpt_icon":0},{"id":"2582876379","title":"Press Release: ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876379","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582876379?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:30","pubTimestamp":1762777800,"startTime":"0","endTime":"0","summary":"Continued progress across LOTIS-7 with updated data anticipated in 2025 and LOTIS-5 with topline data expected in 1H 2026. Updated data from Phase 2 IIT of ZYNLONTA  plus rituximab in patients with r/r follicular lymphoma presented at the 22nd International Workshop on Non-Hodgkin Lymphoma. Recent financing supports expansion of ZYNLONTA in anticipation of 2L+ DLBCL launch with strengthened balance sheet relative to previously disclosed cash runway into 2028. \"The successful completion of our most recent PIPE financing strengthens our balance sheet and provides the resources to further invest in ZYNLONTA  as we anticipate advancing into earlier lines of therapy for DLBCL and into indolent lymphomas,\" said Ameet Mallik, Chief Executive Officer of ADC Therapeutics. \"We look forward to multiple upcoming clinical catalysts expected across LOTIS-7, LOTIS-5, and the ongoing Phase 2 IITs, starting with LOTIS-7 before the end of this year and continuing with data readouts throughout 2026.\". --","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4080","CR","BK4539","BK4232","LENZ","BK4007","BK4195","R","ADCT","BK4505","BK4022","BK4161","BK4231","PIPE","ORR","PFS","BK4211","ADC"],"gpt_icon":0},{"id":"2582879886","title":"Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879886","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879886?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776000,"startTime":"0","endTime":"0","summary":"16.5 months median progression free survival (mPFS) for bezuclastinib plus sunitinib compared to 9.2 months mPFS for sunitinib monotherapy (HR=0.50, CI: 0.39-0.65; p<0.0001) 46% Objective Response Rat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184357/0/en/Cogent-Biosciences-Reports-Positive-Results-from-Bezuclastinib-PEAK-Phase-3-Trial-in-Gastrointestinal-Stromal-Tumors-GIST.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","SKIS","LU1670627923.USD","CCOI","BK4109","PFS","LU1670628061.USD","BK4211","BK4195","ASH","ORR","BK4532","BK4089"],"gpt_icon":0},{"id":"2582101208","title":"Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2582101208","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582101208?lang=en_us&edition=fundamental","pubTime":"2025-11-10 10:01","pubTimestamp":1762740060,"startTime":"0","endTime":"0","summary":"CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology  was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association , the Tengchong Science Forum Organizing Committee Office, the World Association for Integrative Oncology , and the China Institute for Integrative Medicine Development Strategy. Academicians, experts, and scholars from across the nation gathered to focus on innovations in cancer diagnosis and treatment while sharing scientific breakthroughs. At the conference, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.  presented results from multiple clinical studies on its TROP2 ADC sacituzumab tirumotecan as oral presentations.On November 8, Professor Fang Wenfeng from the Cancer Center of Sun Yat-sen University delivered an oral presentation at the conference on preliminary results from a Phase II study evaluating sac-TMT in treating locally advanced or metasta","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/kelun-biotech-presented-trop2-adc-sacituzumab-tirumotecan-results-from-multiple-clinical-studies-at-the-2025-cchio-congress-302609625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","LU1934453819.USD","LU2361044949.HKD","LU0203347892.USD","SG9999014542.SGD","LU0234572021.USD","PFS","PR","BK4007","LU0106261612.USD","LU1934455194.USD","LU0238689110.USD","LU1093756325.SGD","LU2468319806.SGD","LU2023250504.SGD","SG9999014567.USD","LU1699723380.USD","DAR","LU1934455277.USD","BK4534","SG9999015341.SGD","LU2148510915.USD","BK4189","LU1162221912.USD","BK4588","002422","LU1941712348.USD","LU1917777945.USD","LU2361044865.SGD","MSD","LU1721429402.USD","LU1066053197.SGD","LU2461242641.AUD","BK4533","LU0265550946.USD","LU1989772840.SGD","SG9999013999.USD","IE00BSNM7G36.USD","ORR.AU","LU1989772923.USD","ADC","LU2023250843.SGD","ORR","BC","MRK","LU0965509010.AUD","LU1291159041.SGD","LU1037948541.HKD","IE00BFTCPJ56.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":199,"code":"91000000","status":"200"}]}}